Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy
Clinical trial NCT03208712 · TERMINATED
Trial details
- NCT number
- NCT03208712
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2018-08-02
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.